UHS UNIVERSAL HEALTH SERVICES INC
Services-General Medical & Surgical Hospitals, NEC · NYSE · SEC CIK 352915 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY8.0%
TTM net income YoY6.3%
TTM EPS YoY13.7%
Revenue 3-yr CAGR9.4%
Net income 3-yr CAGR29.3%
Margins
Gross margin—
Operating margin10.8%
Net margin8.0%
FCF margin6.1%
EBITDA margin14.5%
Returns
ROE19.8%
ROA9.0%
ROIC (approx.)12.2%
Asset turnover1.13x
Leverage & solvency
Liabilities / assets55.0%
Debt / equity0.75x
Current ratio1.37x
Interest coverage11.34x
Cash quality & payout
Operating cash flow / net income1.41x
Accruals ratio-3.7%
Payout ratio3.3%
Capex / revenue5.1%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 | FY20232023-12-31 | FY20222022-12-31 | FY20212021-12-31 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | $17.36B | $15.83B | $14.28B | $13.40B | $12.64B |
| Operating income | $1.99B | $1.68B | $1.18B | $1.00B | $1.36B |
| Interest expense | $156.07M | $186.11M | $206.67M | $126.89M | $83.67M |
| Pretax income | $1.97B | $1.50B | $940.43M | $866.26M | $1.29B |
| Income tax | $460.96M | $334.83M | $221.12M | $209.28M | $305.68M |
| Net income | $1.49B | $1.14B | $717.79M | $675.61M | $991.59M |
| EBITDA | $2.61B | $2.27B | $1.74B | $1.59B | $1.90B |
| EPS (basic) | 23.42 | 17.16 | 10.35 | 9.23 | 11.99 |
| EPS (diluted) | 23.10 | 16.82 | 10.23 | 9.14 | 11.82 |
| Dividends declared per share | 0.80 | 0.80 | 0.80 | 0.80 | 0.80 |
| Weighted avg. shares (diluted) | 64.46M | 67.90M | 70.12M | 73.83M | 83.69M |
| Balance sheet | |||||
| Cash & equivalents | $137.80M | $125.98M | $119.44M | $102.82M | $115.30M |
| Receivables | $2.60B | $2.18B | $2.24B | $2.02B | $1.75B |
| Current assets | $3.41B | $2.82B | $2.81B | $2.54B | $2.26B |
| PP&E, net | $7.01B | $6.57B | $6.12B | $5.92B | $5.87B |
| Goodwill | $3.99B | $3.93B | $3.93B | $3.91B | $3.96B |
| Intangibles | $75.88M | $76.27M | $77.02M | $78.10M | $81.04M |
| Total assets | $15.53B | $14.47B | $13.97B | $13.49B | $13.09B |
| Current liabilities | $3.24B | $2.21B | $2.01B | $1.91B | $1.98B |
| Short-term debt | $748.16M | $40.06M | $126.69M | $81.45M | $48.41M |
| Long-term debt | $4.00B | $4.46B | $4.79B | $4.73B | $4.14B |
| Total debt | $4.75B | $4.50B | $4.91B | $4.81B | $4.19B |
| Total liabilities | $8.12B | $7.71B | $7.77B | $7.52B | $6.90B |
| Shareholders' equity | $7.28B | $6.67B | $6.15B | $5.92B | $6.09B |
| Net debt | $4.61B | $4.38B | $4.79B | $4.71B | $4.07B |
| Cash flow statement | |||||
| Operating cash flow | $1.86B | $2.07B | $1.27B | $996.02M | $883.70M |
| Capital expenditure | $1.02B | $943.81M | $743.05M | $734.00M | $855.66M |
| Free cash flow | $849.25M | $1.12B | $524.74M | $262.02M | $28.04M |
| Investing cash flow | -$1.07B | -$911.11M | -$763.27M | -$647.30M | -$914.47M |
| Financing cash flow | -$749.73M | -$1.14B | -$493.94M | -$318.40M | -$1.07B |
| Depreciation & amortization | $618.74M | $584.83M | $568.04M | $581.86M | $533.21M |
| Stock-based compensation | $95.69M | $99.35M | $87.72M | $85.38M | $73.69M |
| Dividends paid | $51.27M | $53.35M | $55.48M | $58.45M | $65.90M |
| Share buybacks | $967.95M | $670.75M | $547.36M | $832.92M | $1.22B |
Free plan shows the latest 5 periods; Pro shows all 18 🔒
· This company does not report gross profit in XBRL.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.